Page last updated: 2024-10-18

dihydroxyphenylalanine and Angioblastic Meningioma

dihydroxyphenylalanine has been researched along with Angioblastic Meningioma in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calabria, FF1
Chiaravalloti, A1
Calabria, EN1
Grillea, G1
Schillaci, O1
Miyagi, Y1
Morioka, T1
Otsuka, M1
Fukui, M1

Other Studies

2 other studies available for dihydroxyphenylalanine and Angioblastic Meningioma

ArticleYear
18F-DOPA PET/CT and MRI Findings in a Patient With Multiple Meningiomas.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:8

    Topics: Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; M

2016
Striatal glucose metabolism and [18F]fluorodopa uptake in a patient with tumor-induced hemiparkinsonism.
    Neurosurgery, 1993, Volume: 32, Issue:5

    Topics: Blood Glucose; Corpus Striatum; Dihydroxyphenylalanine; Dominance, Cerebral; Dopamine; Electromyogra

1993